Mode
Text Size
Log in / Sign up
N/A Completed N=21 Randomized Supportive Care

A Randomized Study to Compare a Hydrogel Packing System to Standard Packing During HDR Brachytherapy for Cervical Cancer

Source: ClinicalTrials.gov NCT04499521 ↗
Enrolled (actual)
21
Serious AEs
0.0%
Results posted
Mar 2025
Primary outcomePrimary: Dosimetry Comparison of Packing System in OARs — 3.436; 3.319; 3.636; 3.573 Mean in Dose (Gray)

Summary

In this study, a new, low cost packing system ("BrachyGel VHPS") is being tested as a packing option during brachytherapy along with standard options to make sure that it keeps the unrelated organs away from radiation at least as well as the standard options, and to better understand the safety and patient discomfort associated with BrachyGel VHPS and the standard packing options.

Outcome Measures

OutcomeResultp-value
PRIMARY
Dosimetry Comparison of Packing System in OARs
3.436; 3.319; 3.287; 3.798; 3.636; 3.573
SECONDARY
Adverse Events
2; 0; 2; 0; 0; 3
SECONDARY
Dosimetry Comparison of Packing System in OARs
3.436; 3.319; 3.287; 3.798; 3.636; 3.573

Eligibility Criteria

Inclusion Criteria

  • Biopsy showing cancer of the cervix (squamous cell carcinoma, adenocarcinoma, adenosquamous, neuroendocrine, etc)
  • FIGO IB1 - IVB Staging according to FIGO and TNM guidelines
  • Planning to receive brachytherapy as a part of the definitive treatment for cervical cancer
  • Karnofsky performance status (KPS) ≥ 70 or ECOG status ≤1
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Age ≥ 18 years
  • Agreement to adhere to Lifestyle Considerations throughout study duration

Exclusion Criteria

  • History of pelvis or abdominal radiation therapy (RT) that is not a part of the definitive treatment plan for the cancer of interest"
  • History of total or partial hysterectomy
  • Plan to receive external beam RT (EBRT) alone as the definitive treatment plan for the cancer of interest
  • Known pregnancy or lactation (no pregnancy test required prior to participation)
  • Known contraindications to brachytherapy
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04499521). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search